Piotr Baszuk
Overview
Explore the profile of Piotr Baszuk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
378
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Debniak T, Baszuk P, Duchnik E, Rowinska K, Boer M, Kiedrowicz M, et al.
Biomedicines
. 2025 Feb;
13(2).
PMID: 40002942
The pathogenesis of psoriasis is poorly understood. Increased reactive oxygen species (ROS) and lipid peroxidation are crucial in the inflammatory processes, including psoriasis. Thus, microelements, such as zinc and copper,...
2.
Matuszczak M, Kiljanczyk A, Marciniak W, Derkacz R, Stempa K, Baszuk P, et al.
Hered Cancer Clin Pract
. 2024 Sep;
22(1):19.
PMID: 39300540
Objective: To investigate whether Molybdenum blood level is a marker of cancer risk on BRCA1 carriers. Methods: A prospective cohort study was conducted among 989 initially unaffected women with a...
3.
Blood and Serum Se and Zn Levels and 10-Year Survival of Patients after a Diagnosis of Kidney Cancer
Zlowocka-Perlowska E, Baszuk P, Marciniak W, Derkacz R, Toloczko-Grabarek A, Slojewski M, et al.
Biomedicines
. 2024 Aug;
12(8).
PMID: 39200240
The aim of the project was to evaluate the association between selenium (Se) and zinc (Zn) levels in blood and serum and kidney cancer mortality. In a prospective group of...
4.
Pietrzak S, Marciniak W, Derkacz R, Matuszczak M, Kiljanczyk A, Baszuk P, et al.
Cancers (Basel)
. 2024 Aug;
16(15).
PMID: 39123346
Prostate cancer is the most common cancer diagnosed in men and the second leading cause of death in male cancer patients. The WHO suggests that cobalt is involved in the...
5.
Matuszczak M, Kiljanczyk A, Marciniak W, Derkacz R, Stempa K, Baszuk P, et al.
Antioxidants (Basel)
. 2024 Jul;
13(7).
PMID: 39061909
Pathogenic mutations in BRCA1 (BReast CAncer gene 1) confer high risks of both breast (up to 70%) and ovarian (up to 40%) cancers. Zinc (Zn) and copper (Cu) are essential...
6.
Kiljanczyk A, Matuszczak M, Marciniak W, Derkacz R, Stempa K, Baszuk P, et al.
Nutrients
. 2024 Jun;
16(11).
PMID: 38892720
Breast cancer and ovarian cancer pose a significant risk for BRCA1 carriers, with limited risk-reduction strategies. While improved screening helps in the early detection of breast cancer, preventive measures remain...
7.
Debniak T, Baszuk P, Duchnik E, Rowinska K, Rogoza-Janiszewska E, Boer M, et al.
Biomedicines
. 2024 May;
12(5).
PMID: 38791044
Using an Inductively Coupled Plasma Mass Spectrometer we measured the concentration of selenium and arsenic in serum and blood samples from 336 unselected psoriatic patients and 336 matched healthy controls...
8.
Matuszczak M, Kiljanczyk A, Marciniak W, Derkacz R, Stempa K, Baszuk P, et al.
Antioxidants (Basel)
. 2024 May;
13(5).
PMID: 38790714
BRCA1 mutations predispose women to breast and ovarian cancer. The anticancer effect of zinc is typically linked to its antioxidant abilities and protecting cells against oxidative stress. Zinc regulates key...
9.
Kiljanczyk A, Matuszczak M, Marciniak W, Derkacz R, Stempa K, Baszuk P, et al.
Nutrients
. 2024 May;
16(9).
PMID: 38732616
BRCA1 mutations substantially elevate the risks of breast and ovarian cancer. Various modifiers, including environmental factors, can influence cancer risk. Lead, a known carcinogen, has been associated with various cancers,...
10.
Derkacz R, Marciniak W, Baszuk P, Wysokinska M, Chrzanowska N, Lener M, et al.
Nutrients
. 2024 May;
16(9).
PMID: 38732556
Cadmium (Cd) is a known carcinogen, but its impact on cancer risk at lower concentrations is poorly understood. Previous studies on Cd and cancer risk in men show inconsistent results,...